Senior scientists from the UK’s two big pharma companies GlaxoSmithKline and AstraZeneca say only a rapid and significant increase in government R&D spending will boost the UK life
The independent watchdog for health and social care in England says the country’s NHS faces a ‘precarious’ future because of the level of demands put on it.
The state of California has passed a new law requiring pharmaceutical companies to notify it of price rises in advance – and offer an explanation of why they are necessary.
